Price Alert

Zura Bio Limited (ZURA)

NASDAQ: ZURA · Real-Time Price · USD

2.07

0.04 (1.97%)

At close: Sep 04, 2025, 3:59 PM

2.07

0.00%

Pre-market: Sep 05, 2025, 08:19 AM EDT

1.97% (1D)

Bid	2.07
Market Cap	134.59M
Revenue (ttm)	2K
Net Income (ttm)	-67.76M
EPS (ttm)	-0.74
PE Ratio (ttm)	-2.8
Forward PE	-2.6
Analyst	Buy

Ask	2.13
Volume	179,466
Avg. Volume (20D)	674,237
Open	2.03
Previous Close	2.03
Day's Range	1.97 - 2.08
52-Week Range	0.97 - 5.07
Beta	-0.02

About ZURA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ZURA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ZURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

5 months ago

-10.07%

Zura Bio shares are trading lower after the compan... Unlock content with Pro Subscription

News

2 weeks ago · businesswire.com

Zura Bio to Participate in the Cantor Fitzgerald Global Healthcare Conference

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway anti...

2 weeks ago · https://thefly.com

Zura Bio price target lowered to $2 from $3 at H.C. Wainwright

H.C. Wainwright lowered the firm's price target on Zura Bio to $2 from $3 and keeps a Neutral rating on the shares. The firm updated the company's model post the Q2 report to reflect increases in pote...

3 weeks ago · businesswire.com

Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual...

1 month ago · businesswire.com

Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago · businesswire.com

Zura Bio Announces Chief Financial Officer Transition

HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a rang...

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Cuts Stock Position in Zura Bio Limited (NASDAQ:ZURA)

Squarepoint Ops LLC lessened its stake in Zura Bio Limited (NASDAQ:ZURA – Free Report) by 48.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange C...